PXDT Pixie Dust Technologies Inc

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October, 2023

 

Commission File Number 001-41749

 

PIXIE DUST TECHNOLOGIES, INC.

(Translation of registrant’s name into English)

 

Pixie Dust Technologies, Inc.

2-20-5 Kanda Misaki-cho, Chiyoda-ku
Tokyo, 101-0061, Japan

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: ☒ Form 20-F ☐   Form 40-F

 

 

 

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

 

Issuance of Press Release

 

On October 27, 2023, Pixie Dust Technologies, Inc. (the “Company”) issued a press release to announce a joint research agreement with Tohoku University School of Medicine.

 

The press release furnished in this report as Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press Release of the Company, dated October 27, 2023.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: October 27, 2023	Pixie Dust Technologies, Inc.
	By:	/s/ Yoichi Ochiai
		Name:	Yoichi Ochiai
		Title:	Chief Executive Officer

 

 

 

2

 

Exhibit 99.1

 

Pixie Dust Technologies, Inc. Announces Collaborative Research Agreement with Tohoku University School of Medicine

 

NEW YORK, NY and TOKYO, Japan, Oct. 27, 2023 - Pixie Dust Technologies, Inc. (Nasdaq: PXDT) (the “Company”), a Japanese technology company focused on commercializing innovative products and materials utilizing proprietary wave technology, announced a joint research agreement with Tohoku University School of Medicine (the “University”) for the purpose of developing and commercializing certain non-pharmaceutical skin disease treatments using wave control technology.

 

Since 2020, the Company has had an ongoing partnership with the University, combining the Company’s wave control technology with University resources and knowledge. While the previous focus of this partnership was on a wide range of societal healthcare issues, today’s agreement has the specific focus of pioneering an innovative, non-pharmaceutical approach to skin disease treatment using ultrasonic technology.

 

About Tohoku University

 

Name: National University Corporation Tohoku University

President: Hideo Ohno

Location: 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi Prefecture

Established: June 1907

URL: https://www.tohoku.ac.jp/en/

 

Since its establishment in 1907, Tohoku University has been leading the way in the pursuit of truth, guided by its principles of ‘Research First,’ ‘Open Doors,’ and ‘Practice Oriented Research and Education.’ The University has produced many eminent leaders and achieved globally acclaimed research outcomes that have expanded the horizons of human knowledge and spearheaded transformation and innovation for future societies. In July 2020, the University updated the ‘Vision 2030,’ first laid out in 2018, and formulated the ‘Connected University Strategy.’ The University strongly promoted the digitalization of education, research, and co-creation with society, showcasing the roadmap towards a borderless, diverse, and truly inclusive university through the integrated use of cyberspace and physical spaces. In 2021, the University declared the ‘Green Goals Initiative,’ taking a new step toward creating a prosperous future. Moving forward, the University will continue to evolve alongside society as a comprehensive research university, addressing humanity’s shared challenges such as the Sustainable Development Goals (SDGs), the Great Reset in the post- pandemic era, and achieving carbon neutrality, all grounded on solid research.

 

About Pixie Dust Technologies, Inc.

 

Pixie Dust Technologies, Inc. is a Japanese technology company focused on commercializing innovative products and materials utilizing proprietary wave technology. The Company is currently focusing on two areas of product development: (1) “Personal Care & Diversity”, where wave control technology is applied to mechanobiology and intervention/assistance in vision, hearing, and touch, and (2) “Workspace & Digital Transformation,” where metamaterials (technology that creates properties through structure rather than material) and solutions to commercial design problems, such as in offices or construction sites, are applied.

 

Contact:

 

Pixie Dust Technologies, Inc. PR Department

Inquiry: https://pixiedusttech.com/contact/

 

Tohoku University Graduate School of Medicine / Medical Department Public Relations Office

Tohoku University Hospital Public Relations Office

Contact:

TEL: +81-22-717-8032

E-mail: press@pr.med.tohoku.ac.jp

 

---